×
Merck Revenue 2010-2024 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Merck revenue for the twelve months ending September 30, 2024 was
$63.175B
, a
6.51% increase
year-over-year.
Merck annual revenue for 2023 was
$60.115B
, a
1.4% increase
from 2022.
Merck annual revenue for 2022 was
$59.283B
, a
21.72% increase
from 2021.
Merck annual revenue for 2021 was
$48.704B
, a
17.31% increase
from 2020.
View More
Merck Revenue 2010-2024 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Merck annual revenue for 2023 was
$60.115B
, a
1.4% increase
from 2022.
Merck annual revenue for 2022 was
$59.283B
, a
21.72% increase
from 2021.
Merck annual revenue for 2021 was
$48.704B
, a
17.31% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$759.4B
Novo Nordisk (NVO)
$387.1B
Johnson & Johnson (JNJ)
$342B
AbbVie (ABBV)
$309.5B
AstraZeneca (AZN)
$207.8B
Novartis AG (NVS)
$202.5B
Pfizer (PFE)
$151.4B
Sanofi (SNY)
$123.7B
Bayer (BAYRY)
$20.1B
Innoviva (INVA)
$1.1B